Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.60 |
| ▸ | MAOB | P27338 | 1/20 | 0.59 |
| ▸ | KDM5A | P29375 | 1/20 | 0.59 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.59 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.57 |
| ▸ | NPY2R | P49146 | 7/20 | 0.56 |
| ▸ | NPY4R | P50391 | 7/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.56 |
| ▸ | NPY1R | P25929 | 5/20 | 0.56 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.56 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.55 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.55 |
| ▸ | TFPI | P10646 | 3/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29521532 | 0.91 | KDM1A (0.66) | KDM1AMAOBKDM5AKDM1BEPHA2 | |
| SCHEMBL31307252 | 0.88 | EPHA2 (0.63) | KDM1AMAOBKDM5AKDM1BEPHA2 | |
| SCHEMBL30361699 | 0.88 | NTSR1 (0.59) | KDM1AMAOBKDM5AKDM1BEPHA2 | |
| SCHEMBL17980306 | 0.87 | OPRM1 (0.54) | KDM1AMAOBKDM5AKDM1BEPHA2 | |
| SCHEMBL30901005 | 0.87 | KDM1A (0.59) | KDM1AMAOBKDM5AKDM1BEPHA2 | |
| SCHEMBL30581283 | 0.87 | MAPK8 (0.60) | KDM1AMAOBKDM5AKDM1BNPY2R | |
| SCHEMBL31031455 | 0.87 | KDM1A (0.65) | KDM1AMAOBKDM5AKDM1BEPHA2 | |
| SCHEMBL29903316 | 0.87 | NPY2R (0.64) | KDM1AMAOBKDM5AKDM1BEPHA2 | |
| SCHEMBL17980318 | 0.87 | KDM1A (0.55) | KDM1AMAOBKDM5AKDM1BEPHA2 | |
| SCHEMBL31031546 | 0.86 | KDM1A (0.67) | KDM1AMAOBKDM5AKDM1BNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120365373-A | Construction and activity evaluation of anti-cancer peptide inhibitor GLP2 based on Grb2 preferential binding motif | 滨州医学院 | 2025-07-25 | — | — | CN | disclosed |